BCG Hsp70–CD123 Immunoconjugate Targets Childhood AML
In a groundbreaking advancement for pediatric oncology, researchers have unveiled a novel immunotherapy strategy that holds promise to revolutionize treatment outcomes for children diagnosed with...
















